Researchers estimate that about 17% of patients who get COVID-19 will go on to develop Long COVID, or the continuation of wide-ranging symptoms after an initial SARS-CoV-2 infection.
This report describes a review of Oregon death certificate data to assess whether young people in Oregon might be dying after receiving a COVID-19 vaccine.
A self-amplifying mRNA vaccine shows promise in this new modality by eliciting neutralizing antibodies against the SARS-CoV-2 Omicron (BA.1) variant in a phase 2/3 trial.